TITLE

The Effect of the Type of Hemodialysis Buffer on the QTc Interval in Patients on Chronic Hemodialysis

AUTHOR(S)
Hekmat, Reza; Bahrami, Abddollah; Ahmadi, Mostafa; Nazari, Hossein
PUB. DATE
March 2009
SOURCE
Iranian Journal of Medical Sciences;Mar2009, Vol. 34 Issue 1, p29
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Identifying the sources of variation in QTc measurements is important for preventing arrhythmias during and after hemodialysis. The present study was designed to determine the correlation between the type of hemodialysis buffer and the changes in QTc interval in patients on chronic hemodialysis. Methods: Fifty-nine patients on chronic hemodialysis who referred in winter 2007 to hemodialysis centers of Ghaem and Hashemi Nejad hospitals, in Mashhad, Iran, were divided into two groups according to their last dialysate buffer: acetate or bicarbonate. Electrocardiography, arterial blood gas parameters, serum K+, Na+, ionized calcium, and albumin levels were measured prior to and after hemodialysis in all patients. Results: All arterial blood gas parameters and serum electrolytes concentrations were increased except K+ levels that were significantly decreased with hemodialysis. PCO2 and QTc intervals were slightly increased in all patients, however this increase was not statistically significant. We found that the type of dialysate affected the QTc interval, HCO3, base excess, base excess of extra cellular fluid, and base buffer changes with no effect on ionized calcium, pH, PCO2, and serum albumin concentration. QTc interval was prolonged by using bicarbonate and shortened by using acetate dialysate buffer. We found no correlation between the variations of QTc interval and serum electrolytes or arterial blood gas parameters in either group. Conclusion: Bicarbonate buffer use in hemodialysis prolonged QTc interval and acetate buffer shortened it. This effect is independent of serum electrolytes and pH changes during hemodialysis. The effect of bicarbonate buffer is probably due to more tolerability of ultra filtration, more effective edema reduction and augmented body electro-conductivity.
ACCESSION #
46815624

 

Related Articles

  • Basics of base in hemodialysis solution: Dialysate buffer production, delivery and decontamination. Desai, N. // Indian Journal of Nephrology;Jul/Aug2015, Vol. 25 Issue 4, p189 

    Hemodialysis requires the use of high volumes of freshly prepared, clean dialysate to foster the removal of low molecular weight metabolites (i.e., urea) and to correct the electrolyte and acid‑base imbalance of chronic renal failure. Dialysate is produced by mixing clean, AAMI grade...

  • Hyperkalemia masking left ventricular hypertrophy in electrocardiogram in a patient with end-stage renal disease. Sai Naresh, V. V.; Ramakrishna, Ch. V.; Ramakrishna, P.; Siva Kumar, V. // Indian Journal of Nephrology;Jan-Mar2008, Vol. 18 Issue 1, p22 

    A patient of severe chronic renal failure presented with hyperkalemic electrocardiographic (ECG) changes and hyperkalemia. Following a session of hemodialysis, when he reverted to normokalemia, the repeat ECG revealed left ventricular hypertrophy (LVH). Thus we confronted with a situation of...

  • Lidoflazine and Propranolol Combination Treatment in Chronic Stable Angina. Charlap, Shlomo; Kimmel, Bruce; Berezow, Joel; Molinas, Sharon; Strom, Joel; Wexler, John; Willens, Howard; Klein, Neal; Pollack, Simcha; Frishman, William H. // Angiology;Apr1985, Vol. 36 Issue 4, p240 

    The short-term (1 month) and long-term (6 months) safety of combination lidoflazine-propranolol therapy was investigated in an open trial of 15 patients with stable angina of effort. The possible advantages of adding lidoflazine (titrated to 360 mg daily) to patients having a therapeutic...

  • Telemonitoring of implantable cardiac devices: hurdles towards personalised medicine. Heidbuchel, Hein // Heart;Jun2011, Vol. 97 Issue 11, p931 

    The article discusses the effect of implantable cardiac devices telemonitoring on personalized medicine. It mentions that telemedicine is helpful in hospitals with patients who have chronic conditions that should be followed up constantly. According to the author, remote monitoring of patients...

  • Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. Mortier, Siska; Faict, Dirk; Lameire, Norbert H.; De Vriese, An S. // Kidney International;Apr2005, Vol. 67 Issue 4, p1559 

    Benefits of switching from a conventional to a low-glucose degradation product (GDP) bicarbonate/lactate-buffered dialysis solution in a rat model.Background.Long-term exposure to standard peritoneal dialysis fluid (PDF) results in alterations in peritoneal morphology and function. Studies...

  • Comparison of Peritoneal Dialysis Solutions. Crawford-Bonadio, Terri L.; Diaz-Buxo, Jose A. // Nephrology Nursing Journal;Sep/Oct2004, Vol. 31 Issue 5, p500 

    The article describes similarities and differences in conventional and new peritoneal dialysis solutions in terms of biocompatibility, osmotic agents, and buffer bases. It discusses the main strategies that have been employed to improve the characteristics of peritoneal dialysis solutions, and...

  • Right rhythms.  // Prevention;Nov94, Vol. 46 Issue 11, p48 

    Looks at study results that suggest that the asthma drug theophylline may restore normal heart rhythms to patients whose hearts develop arrhythmias after heart attacks. Report presented at the International Symposium on Adenosine and Adenine Nucleotides in May 1994; How the drug works.

  • Cardioprotective Effects of ω-3 PUFAs in Chronic Kidney Disease. Su Mi Lee; Won Suk An // BioMed Research International;2013, p1 

    The prevalence rate of chronic kidney disease (CKD) is increasing worldwide, and cardiovascular disease (CVD) is a main cause of death in patients with CKD. The high incidence of CVD in CKD patients is related to chronic inflammation, dyslipidemia, malnutrition, atherosclerosis, and vascular...

  • Preparation and biodistribution study of technetium-99m-labeled quercetin as a potential radical scavenging agent. Hosseinimehr, Seyed Jalal; Ahmadi, Amirhossein; Taghvai, Reza // Journal of Radioanalytical & Nuclear Chemistry;Jun2010, Vol. 284 Issue 3, p563 

    Free radicals and oxidative stress are the primary causes of several chronic diseases such as cancer and heart disease. Quercetin is a natural compound with potent antioxidant activity. We have prepared and evaluated technetium-99m (99mTc)-labeled quercetin as a potential radical scavenging...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics